APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tag Antibody

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tag Antibody Market Outlook and Growth Opportunities 2026

27 December 2025206 pages

Choose your research edition.

Industry ResearchTag Antibody Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Tag Antibody Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Tag Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tag Antibody Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Tag Antibody Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Tag Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tag Antibody market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tag Antibody market include Sino Biological, GenScript, Sino Biological, Santa Cruz Biotechnology, R&D Systems, OriGene, Novus Biologicals, Nacalai USA and Merck Millipore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tag Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tag Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tag Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tag Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Tag Antibody Segment by Company

Sino Biological

GenScript

Sino Biological

Santa Cruz Biotechnology

R&D Systems

OriGene

Novus Biologicals

Nacalai USA

Merck Millipore

GeneTex

Fortis Life Sciences

EpigenTek

Creative Diagnostics

Bio-Techne

Bio-Rad Antibodies

BiologicsCorp

Bio X Cell

Applied Biological Materials

Agrisera antibodies

Abcam

Tag Antibody Segment by Type

His Tag Antibody

HA Tag Antibody

Other

Tag Antibody Segment by Application

Western Blot

Flow Cytometry

Immune Precipitation

Immuno Fluorescence

Other

Tag Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tag Antibody status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tag Antibody market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tag Antibody significant trends, drivers, influence factors in global and regions.

6. To analyze Tag Antibody competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tag Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tag Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tag Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tag Antibody market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tag Antibody industry.

Chapter 3: Detailed analysis of Tag Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tag Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tag Antibody in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tag Antibody Industry Trends Table 2. Tag Antibody Industry Drivers Table 3. Tag Antibody Industry Opportunities and Challenges Table 4. Tag Antibody Industry Restraints Table 5. Global Tag Antibody Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tag Antibody Revenue Share by Company (2021-2026) Table 7. Global Tag Antibody Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Tag Antibody Sales Volume Share by Company (2021-2026) Table 9. Global Tag Antibody Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tag Antibody Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tag Antibody Key Company Manufacturing Base & Headquarters Table 12. Global Tag Antibody Company, Product Type & Application Table 13. Global Tag Antibody Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tag Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of His Tag Antibody Table 18. Significant Companies of HA Tag Antibody Table 19. Significant Companies of Other Table 20. Global Tag Antibody Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Tag Antibody Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Tag Antibody Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Tag Antibody Sales Volume Share by Type (2021-2026) Table 24. Global Tag Antibody Sales Volume Share by Type (2027-2032) Table 25. Global Tag Antibody Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tag Antibody Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Tag Antibody Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Tag Antibody Sales Value Share by Type (2021-2026) Table 29. Global Tag Antibody Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Western Blot Table 31. Significant Companies of Flow Cytometry Table 32. Significant Companies of Immune Precipitation Table 33. Significant Companies of Immuno Fluorescence Table 34. Significant Companies of Other Table 35. Global Tag Antibody Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Tag Antibody Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Tag Antibody Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Tag Antibody Sales Volume Share by Application (2021-2026) Table 39. Global Tag Antibody Sales Volume Share by Application (2027-2032) Table 40. Global Tag Antibody Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Tag Antibody Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Tag Antibody Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Tag Antibody Sales Value Share by Application (2021-2026) Table 44. Global Tag Antibody Sales Value Share by Application (2027-2032) Table 45. Global Tag Antibody Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Tag Antibody Sales by Region (2021-2026) & (K Units) Table 47. Global Tag Antibody Sales Market Share by Region (2021-2026) Table 48. Global Tag Antibody Sales by Region (2027-2032) & (K Units) Table 49. Global Tag Antibody Sales Market Share by Region (2027-2032) Table 50. Global Tag Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Tag Antibody Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Tag Antibody Sales Value Share by Region (2021-2026) Table 53. Global Tag Antibody Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Tag Antibody Sales Value Share by Region (2027-2032) Table 55. Global Tag Antibody Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Tag Antibody Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Tag Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Tag Antibody Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tag Antibody Sales by Country (2021-2026) & (K Units) Table 60. Global Tag Antibody Sales Market Share by Country (2021-2026) Table 61. Global Tag Antibody Sales by Country (2027-2032) & (K Units) Table 62. Global Tag Antibody Sales Market Share by Country (2027-2032) Table 63. Global Tag Antibody Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Tag Antibody Sales Value Market Share by Country (2021-2026) Table 65. Global Tag Antibody Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Tag Antibody Sales Value Market Share by Country (2027-2032) Table 67. Sino Biological Company Information Table 68. Sino Biological Business Overview Table 69. Sino Biological Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sino Biological Tag Antibody Product Portfolio Table 71. Sino Biological Recent Development Table 72. GenScript Company Information Table 73. GenScript Business Overview Table 74. GenScript Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GenScript Tag Antibody Product Portfolio Table 76. GenScript Recent Development Table 77. Sino Biological Company Information Table 78. Sino Biological Business Overview Table 79. Sino Biological Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sino Biological Tag Antibody Product Portfolio Table 81. Sino Biological Recent Development Table 82. Santa Cruz Biotechnology Company Information Table 83. Santa Cruz Biotechnology Business Overview Table 84. Santa Cruz Biotechnology Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Santa Cruz Biotechnology Tag Antibody Product Portfolio Table 86. Santa Cruz Biotechnology Recent Development Table 87. R&D Systems Company Information Table 88. R&D Systems Business Overview Table 89. R&D Systems Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. R&D Systems Tag Antibody Product Portfolio Table 91. R&D Systems Recent Development Table 92. OriGene Company Information Table 93. OriGene Business Overview Table 94. OriGene Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. OriGene Tag Antibody Product Portfolio Table 96. OriGene Recent Development Table 97. Novus Biologicals Company Information Table 98. Novus Biologicals Business Overview Table 99. Novus Biologicals Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novus Biologicals Tag Antibody Product Portfolio Table 101. Novus Biologicals Recent Development Table 102. Nacalai USA Company Information Table 103. Nacalai USA Business Overview Table 104. Nacalai USA Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Nacalai USA Tag Antibody Product Portfolio Table 106. Nacalai USA Recent Development Table 107. Merck Millipore Company Information Table 108. Merck Millipore Business Overview Table 109. Merck Millipore Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Merck Millipore Tag Antibody Product Portfolio Table 111. Merck Millipore Recent Development Table 112. GeneTex Company Information Table 113. GeneTex Business Overview Table 114. GeneTex Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GeneTex Tag Antibody Product Portfolio Table 116. GeneTex Recent Development Table 117. Fortis Life Sciences Company Information Table 118. Fortis Life Sciences Business Overview Table 119. Fortis Life Sciences Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Fortis Life Sciences Tag Antibody Product Portfolio Table 121. Fortis Life Sciences Recent Development Table 122. EpigenTek Company Information Table 123. EpigenTek Business Overview Table 124. EpigenTek Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. EpigenTek Tag Antibody Product Portfolio Table 126. EpigenTek Recent Development Table 127. Creative Diagnostics Company Information Table 128. Creative Diagnostics Business Overview Table 129. Creative Diagnostics Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Creative Diagnostics Tag Antibody Product Portfolio Table 131. Creative Diagnostics Recent Development Table 132. Bio-Techne Company Information Table 133. Bio-Techne Business Overview Table 134. Bio-Techne Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bio-Techne Tag Antibody Product Portfolio Table 136. Bio-Techne Recent Development Table 137. Bio-Rad Antibodies Company Information Table 138. Bio-Rad Antibodies Business Overview Table 139. Bio-Rad Antibodies Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Bio-Rad Antibodies Tag Antibody Product Portfolio Table 141. Bio-Rad Antibodies Recent Development Table 142. BiologicsCorp Company Information Table 143. BiologicsCorp Business Overview Table 144. BiologicsCorp Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. BiologicsCorp Tag Antibody Product Portfolio Table 146. BiologicsCorp Recent Development Table 147. Bio X Cell Company Information Table 148. Bio X Cell Business Overview Table 149. Bio X Cell Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Bio X Cell Tag Antibody Product Portfolio Table 151. Bio X Cell Recent Development Table 152. Applied Biological Materials Company Information Table 153. Applied Biological Materials Business Overview Table 154. Applied Biological Materials Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Applied Biological Materials Tag Antibody Product Portfolio Table 156. Applied Biological Materials Recent Development Table 157. Agrisera antibodies Company Information Table 158. Agrisera antibodies Business Overview Table 159. Agrisera antibodies Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Agrisera antibodies Tag Antibody Product Portfolio Table 161. Agrisera antibodies Recent Development Table 162. Abcam Company Information Table 163. Abcam Business Overview Table 164. Abcam Tag Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Abcam Tag Antibody Product Portfolio Table 166. Abcam Recent Development Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Tag Antibody Distributors List Table 170. Tag Antibody Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Tag Antibody Product Image Figure 2. Global Tag Antibody Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tag Antibody Sales (2021-2032) & (K Units) Figure 5. Global Tag Antibody Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tag Antibody Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. His Tag Antibody Image Figure 10. HA Tag Antibody Image Figure 11. Other Image Figure 12. Global Tag Antibody Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Tag Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Tag Antibody Sales Volume Share by Type (2021-2032) Figure 15. Global Tag Antibody Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Tag Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Tag Antibody Sales Value Share by Type (2021-2032) Figure 18. Western Blot Image Figure 19. Flow Cytometry Image Figure 20. Immune Precipitation Image Figure 21. Immuno Fluorescence Image Figure 22. Other Image Figure 23. Global Tag Antibody Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Tag Antibody Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Tag Antibody Sales Volume Share by Application (2021-2032) Figure 26. Global Tag Antibody Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tag Antibody Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Tag Antibody Sales Value Share by Application (2021-2032) Figure 29. Global Tag Antibody Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Tag Antibody Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Tag Antibody Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Tag Antibody Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 34. North America Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 40. South America Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Tag Antibody Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Tag Antibody Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Tag Antibody Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Tag Antibody Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Tag Antibody Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Tag Antibody Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Tag Antibody Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • His Tag Antibody
  • HA Tag Antibody
  • Other
Applications
  • Western Blot
  • Flow Cytometry
  • Immune Precipitation
  • Immuno Fluorescence
  • Other
Companies covered
  • Sino Biological
  • GenScript
  • Sino Biological
  • Santa Cruz Biotechnology
  • R&D Systems
  • OriGene
  • Novus Biologicals
  • Nacalai USA
  • Merck Millipore
  • GeneTex
  • Fortis Life Sciences
  • EpigenTek
  • Creative Diagnostics
  • Bio-Techne
  • Bio-Rad Antibodies
  • BiologicsCorp
  • Bio X Cell
  • Applied Biological Materials
  • Agrisera antibodies
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tag Antibody Sales Value (2021-2032)
  4. 1.2.2 Global Tag Antibody Sales Volume (2021-2032)
  5. 1.2.3 Global Tag Antibody Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tag Antibody Market Dynamics
  1. 2.1 Tag Antibody Industry Trends
  2. 2.2 Tag Antibody Industry Drivers
  3. 2.3 Tag Antibody Industry Opportunities and Challenges
  4. 2.4 Tag Antibody Industry Restraints
3 Tag Antibody Market by Company
  1. 3.1 Global Tag Antibody Company Revenue Ranking in 2025
  2. 3.2 Global Tag Antibody Revenue by Company (2021-2026)
  3. 3.3 Global Tag Antibody Sales Volume by Company (2021-2026)
  4. 3.4 Global Tag Antibody Average Price by Company (2021-2026)
  5. 3.5 Global Tag Antibody Company Ranking (2024-2026)
  6. 3.6 Global Tag Antibody Company Manufacturing Base and Headquarters
  7. 3.7 Global Tag Antibody Company Product Type and Application
  8. 3.8 Global Tag Antibody Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tag Antibody Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tag Antibody Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tag Antibody Market by Type
  1. 4.1 Tag Antibody Type Introduction
  2. 4.1.1 His Tag Antibody
  3. 4.1.2 HA Tag Antibody
  4. 4.1.3 Other
  5. 4.2 Global Tag Antibody Sales Volume by Type
  6. 4.2.1 Global Tag Antibody Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tag Antibody Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Tag Antibody Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Tag Antibody Sales Value by Type
  10. 4.3.1 Global Tag Antibody Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Tag Antibody Sales Value by Type (2021-2032)
  12. 4.3.3 Global Tag Antibody Sales Value Share by Type (2021-2032)
5 Tag Antibody Market by Application
  1. 5.1 Tag Antibody Application Introduction
  2. 5.1.1 Western Blot
  3. 5.1.2 Flow Cytometry
  4. 5.1.3 Immune Precipitation
  5. 5.1.4 Immuno Fluorescence
  6. 5.1.5 Other
  7. 5.2 Global Tag Antibody Sales Volume by Application
  8. 5.2.1 Global Tag Antibody Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Tag Antibody Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Tag Antibody Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Tag Antibody Sales Value by Application
  12. 5.3.1 Global Tag Antibody Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Tag Antibody Sales Value by Application (2021-2032)
  14. 5.3.3 Global Tag Antibody Sales Value Share by Application (2021-2032)
6 Tag Antibody Regional Sales and Value Analysis
  1. 6.1 Global Tag Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tag Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Tag Antibody Sales by Region: 2021-2026
  4. 6.2.2 Global Tag Antibody Sales by Region (2027-2032)
  5. 6.3 Global Tag Antibody Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tag Antibody Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tag Antibody Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tag Antibody Sales Value by Region (2027-2032)
  9. 6.5 Global Tag Antibody Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tag Antibody Sales Value (2021-2032)
  12. 6.6.2 North America Tag Antibody Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tag Antibody Sales Value (2021-2032)
  15. 6.7.2 Europe Tag Antibody Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tag Antibody Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tag Antibody Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tag Antibody Sales Value (2021-2032)
  21. 6.9.2 South America Tag Antibody Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tag Antibody Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tag Antibody Sales Value Share by Country, 2025 VS 2032
7 Tag Antibody Country-level Sales and Value Analysis
  1. 7.1 Global Tag Antibody Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tag Antibody Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tag Antibody Sales by Country (2021-2032)
  4. 7.3.1 Global Tag Antibody Sales by Country (2021-2026)
  5. 7.3.2 Global Tag Antibody Sales by Country (2027-2032)
  6. 7.4 Global Tag Antibody Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tag Antibody Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tag Antibody Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tag Antibody Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tag Antibody Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tag Antibody Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tag Antibody Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tag Antibody Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tag Antibody Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tag Antibody Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tag Antibody Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tag Antibody Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tag Antibody Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tag Antibody Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tag Antibody Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tag Antibody Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tag Antibody Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tag Antibody Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tag Antibody Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tag Antibody Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tag Antibody Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tag Antibody Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tag Antibody Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tag Antibody Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tag Antibody Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tag Antibody Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tag Antibody Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tag Antibody Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tag Antibody Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tag Antibody Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tag Antibody Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tag Antibody Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tag Antibody Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tag Antibody Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tag Antibody Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tag Antibody Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tag Antibody Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tag Antibody Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tag Antibody Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tag Antibody Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tag Antibody Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tag Antibody Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tag Antibody Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tag Antibody Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tag Antibody Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tag Antibody Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tag Antibody Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tag Antibody Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tag Antibody Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tag Antibody Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tag Antibody Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tag Antibody Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tag Antibody Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tag Antibody Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tag Antibody Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tag Antibody Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tag Antibody Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tag Antibody Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tag Antibody Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tag Antibody Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tag Antibody Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tag Antibody Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tag Antibody Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tag Antibody Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tag Antibody Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tag Antibody Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tag Antibody Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tag Antibody Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tag Antibody Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tag Antibody Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tag Antibody Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tag Antibody Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tag Antibody Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tag Antibody Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tag Antibody Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tag Antibody Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tag Antibody Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tag Antibody Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tag Antibody Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tag Antibody Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tag Antibody Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tag Antibody Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tag Antibody Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tag Antibody Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tag Antibody Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tag Antibody Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tag Antibody Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sino Biological
  2. 8.1.1 Sino Biological Company Information
  3. 8.1.2 Sino Biological Business Overview
  4. 8.1.3 Sino Biological Tag Antibody Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sino Biological Tag Antibody Product Portfolio
  6. 8.1.5 Sino Biological Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript Tag Antibody Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GenScript Tag Antibody Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Sino Biological
  14. 8.3.1 Sino Biological Company Information
  15. 8.3.2 Sino Biological Business Overview
  16. 8.3.3 Sino Biological Tag Antibody Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sino Biological Tag Antibody Product Portfolio
  18. 8.3.5 Sino Biological Recent Developments
  19. 8.4 Santa Cruz Biotechnology
  20. 8.4.1 Santa Cruz Biotechnology Company Information
  21. 8.4.2 Santa Cruz Biotechnology Business Overview
  22. 8.4.3 Santa Cruz Biotechnology Tag Antibody Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Santa Cruz Biotechnology Tag Antibody Product Portfolio
  24. 8.4.5 Santa Cruz Biotechnology Recent Developments
  25. 8.5 R&D Systems
  26. 8.5.1 R&D Systems Company Information
  27. 8.5.2 R&D Systems Business Overview
  28. 8.5.3 R&D Systems Tag Antibody Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 R&D Systems Tag Antibody Product Portfolio
  30. 8.5.5 R&D Systems Recent Developments
  31. 8.6 OriGene
  32. 8.6.1 OriGene Company Information
  33. 8.6.2 OriGene Business Overview
  34. 8.6.3 OriGene Tag Antibody Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 OriGene Tag Antibody Product Portfolio
  36. 8.6.5 OriGene Recent Developments
  37. 8.7 Novus Biologicals
  38. 8.7.1 Novus Biologicals Company Information
  39. 8.7.2 Novus Biologicals Business Overview
  40. 8.7.3 Novus Biologicals Tag Antibody Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novus Biologicals Tag Antibody Product Portfolio
  42. 8.7.5 Novus Biologicals Recent Developments
  43. 8.8 Nacalai USA
  44. 8.8.1 Nacalai USA Company Information
  45. 8.8.2 Nacalai USA Business Overview
  46. 8.8.3 Nacalai USA Tag Antibody Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nacalai USA Tag Antibody Product Portfolio
  48. 8.8.5 Nacalai USA Recent Developments
  49. 8.9 Merck Millipore
  50. 8.9.1 Merck Millipore Company Information
  51. 8.9.2 Merck Millipore Business Overview
  52. 8.9.3 Merck Millipore Tag Antibody Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Millipore Tag Antibody Product Portfolio
  54. 8.9.5 Merck Millipore Recent Developments
  55. 8.10 GeneTex
  56. 8.10.1 GeneTex Company Information
  57. 8.10.2 GeneTex Business Overview
  58. 8.10.3 GeneTex Tag Antibody Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GeneTex Tag Antibody Product Portfolio
  60. 8.10.5 GeneTex Recent Developments
  61. 8.11 Fortis Life Sciences
  62. 8.11.1 Fortis Life Sciences Company Information
  63. 8.11.2 Fortis Life Sciences Business Overview
  64. 8.11.3 Fortis Life Sciences Tag Antibody Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fortis Life Sciences Tag Antibody Product Portfolio
  66. 8.11.5 Fortis Life Sciences Recent Developments
  67. 8.12 EpigenTek
  68. 8.12.1 EpigenTek Company Information
  69. 8.12.2 EpigenTek Business Overview
  70. 8.12.3 EpigenTek Tag Antibody Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 EpigenTek Tag Antibody Product Portfolio
  72. 8.12.5 EpigenTek Recent Developments
  73. 8.13 Creative Diagnostics
  74. 8.13.1 Creative Diagnostics Company Information
  75. 8.13.2 Creative Diagnostics Business Overview
  76. 8.13.3 Creative Diagnostics Tag Antibody Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Creative Diagnostics Tag Antibody Product Portfolio
  78. 8.13.5 Creative Diagnostics Recent Developments
  79. 8.14 Bio-Techne
  80. 8.14.1 Bio-Techne Company Information
  81. 8.14.2 Bio-Techne Business Overview
  82. 8.14.3 Bio-Techne Tag Antibody Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Techne Tag Antibody Product Portfolio
  84. 8.14.5 Bio-Techne Recent Developments
  85. 8.15 Bio-Rad Antibodies
  86. 8.15.1 Bio-Rad Antibodies Company Information
  87. 8.15.2 Bio-Rad Antibodies Business Overview
  88. 8.15.3 Bio-Rad Antibodies Tag Antibody Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bio-Rad Antibodies Tag Antibody Product Portfolio
  90. 8.15.5 Bio-Rad Antibodies Recent Developments
  91. 8.16 BiologicsCorp
  92. 8.16.1 BiologicsCorp Company Information
  93. 8.16.2 BiologicsCorp Business Overview
  94. 8.16.3 BiologicsCorp Tag Antibody Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BiologicsCorp Tag Antibody Product Portfolio
  96. 8.16.5 BiologicsCorp Recent Developments
  97. 8.17 Bio X Cell
  98. 8.17.1 Bio X Cell Company Information
  99. 8.17.2 Bio X Cell Business Overview
  100. 8.17.3 Bio X Cell Tag Antibody Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Bio X Cell Tag Antibody Product Portfolio
  102. 8.17.5 Bio X Cell Recent Developments
  103. 8.18 Applied Biological Materials
  104. 8.18.1 Applied Biological Materials Company Information
  105. 8.18.2 Applied Biological Materials Business Overview
  106. 8.18.3 Applied Biological Materials Tag Antibody Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Applied Biological Materials Tag Antibody Product Portfolio
  108. 8.18.5 Applied Biological Materials Recent Developments
  109. 8.19 Agrisera antibodies
  110. 8.19.1 Agrisera antibodies Company Information
  111. 8.19.2 Agrisera antibodies Business Overview
  112. 8.19.3 Agrisera antibodies Tag Antibody Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Agrisera antibodies Tag Antibody Product Portfolio
  114. 8.19.5 Agrisera antibodies Recent Developments
  115. 8.20 Abcam
  116. 8.20.1 Abcam Company Information
  117. 8.20.2 Abcam Business Overview
  118. 8.20.3 Abcam Tag Antibody Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Abcam Tag Antibody Product Portfolio
  120. 8.20.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tag Antibody Value Chain Analysis
  2. 9.1.1 Tag Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tag Antibody Sales Mode & Process
  6. 9.2 Tag Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tag Antibody Distributors
  9. 9.2.3 Tag Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst